News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
415
Sources here
19
Companies here
8
Search results Stored financial headlines

Active search

415 matching headlines

Ticker or company: SPIRMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

5 Insightful Analyst Questions From Inspire Medical Systems’s Q2 Earnings Call

Inspire Medical Systems (INSP) surpassed Q2 analyst expectations with improved operating income and positive cash flow, driven by better coding clarity and cost discipline. Management raised its full-year revenue and Adjusted EPS guidance, demonstrating resilience despite a year-on-year revenue decline. Analyst questions focused on …

INSP main company
Sharemaestro market context Price above Trend Line 52 weeks -40.5% INSP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

InspireMD Q2 Results: Second Quarter 2026 Earnings Release Date Set

InspireMD, Inc. will release its second quarter 2026 financial results on August 17, 2026, followed by a conference call and webcast at 8:30 a.m. ET. The company, known for its CGuard Prime carotid stent system, will discuss its financial performance and operational updates, including …

NSPR main company
Sharemaestro market context Price below Trend Line 52 weeks -58.6% · Next-week setup negative 42.7% NSPR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

InspireMD Schedules 8:30 a.m. Call to Discuss Q2 Results

InspireMD (Nasdaq: NSPR) announced it will release its second quarter 2026 financial results on Monday, August 17, 2026. The company will host a conference call and live audio webcast at 8:30 a.m. Eastern Time to discuss the results and recent highlights. Investors can participate …

NSPR main company
Sharemaestro market context Price below Trend Line 52 weeks -58.6% · Next-week setup negative 42.7% NSPR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inspire Medical Systems (INSP) Is Up 19.8% After Q2 Profit And Higher 2026 Guidance - Has The Bull Case Changed?

Inspire Medical Systems reported a swing to profit in Q2 2026 and raised its full-year 2026 revenue guidance, leading to a 19.8% stock increase. Despite this, the company faces ongoing challenges with the Inspire V rollout, marketing spend, and reimbursement policies. The article questions …

INSP main company
Sharemaestro market context Price above Trend Line 52 weeks -40.5% INSP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 8K Aspire Biopharma Holdings Inc For: 10 August By Investing.com

This article reports on the filing of a Form 8K by Aspire Biopharma Holdings Inc. for August 10. The filing indicates a significant event or change at the company, as per SEC regulations. The content is brief, primarily serving as an announcement of the …

ASBP main company
Sharemaestro market context Price below Trend Line 52 weeks -98.8% · Next-week setup negative 44.9% ASBP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aspire Biopharma Closes Acquisition of FireFish Units Under Asset and Equity Purchase Agreement

Aspire Biopharma has completed its acquisition of specified subsidiaries and assets from FireFish, a move aimed at expanding its business. To facilitate the closing, an escrow agreement was established on August 6, 2026, making the acquisition automatic upon payment. Concurrently, Aspire Biopharma secured $3.0 …

ASBP main company
Sharemaestro market context Price below Trend Line 52 weeks -98.8% · Next-week setup negative 44.9% ASBP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue

Aspire Biopharma has completed its acquisition of Dura Driver Control Systems (DCS), a tier-one automotive supplier, for $30 million in cash. This acquisition is a strategic move to transform Aspire into a diversified, high-revenue enterprise, leveraging DCS's global manufacturing presence, extensive intellectual property, and …

ASBP main company
Sharemaestro market context Price below Trend Line 52 weeks -98.8% · Next-week setup negative 44.9% ASBP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal

Aspire Biopharma Holdings (NASDAQ: ASBP) has completed its $30 million acquisition of Dura Driver Control Systems (DCS), marking its entry into the automotive and mobility-control market. The deal makes DCS a wholly-owned subsidiary, expected to add significant revenue, earnings, and cash flow to Aspire's …

ASBP main company
Sharemaestro market context Price below Trend Line 52 weeks -98.8% · Next-week setup negative 44.9% ASBP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dimensional Fund Advisors LP Trims Holdings in Inspire Medical Systems, Inc. $INSP

Dimensional Fund Advisors LP reduced its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 31.3% in the first quarter, selling over 106,000 shares but retaining a significant holding valued at $12.1 million. Despite this trimming, institutional investors collectively own 94.91% of the company. Inspire …

INSP main company
Sharemaestro market context Price above Trend Line 52 weeks -40.5% INSP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Spire Q3 Earnings Call Highlights

Spire (SR) reported a fiscal third-quarter adjusted loss of $0.26 per share, an improvement from the previous year, as the company transitions to a fully regulated business model after divesting Spire Marketing and Spire Storage. The company reaffirmed its fiscal 2026 and 2027 adjusted …

SR main company
Sharemaestro market context Price below Trend Line 52 weeks +10.7% · Next-week setup positive 60.8% SR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack

Aspire Biopharma Holdings, Inc. announced the launch of its BUZZ BOMB(TM) Convenience Store Pack, expanding its retail presence in the energy category. BUZZ BOMB(TM) is a dry powder caffeine product delivered in single-serving stick packs designed for sublingual use, offering a rapid caffeine boost …

ASBP main company
Sharemaestro market context Price below Trend Line 52 weeks -98.8% · Next-week setup negative 44.9% ASBP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ETFs Investing in Spire Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Spire Inc. (LGR). It provides details such as market value, weight, issuer, management style, focus, expense ratio, assets under management (AUM), price, and 3-year NAV total return for each ETF. The listed …

SR main company
Sharemaestro market context Price below Trend Line 52 weeks +10.7% · Next-week setup positive 60.8% SR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Spire Inc. (SR) Affects Rotational Strategy Timing

This article analyzes Spire Inc. (NYSE: SR) with a focus on how it influences rotational strategy timing, identifying a near-term strong sentiment despite neutral mid and long-term outlooks. AI models provide distinct trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and …

SR main company
Sharemaestro market context Price below Trend Line 52 weeks +10.7% · Next-week setup positive 60.8% SR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Beat: Spire Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Spire Inc. (NYSE:SR) recently announced strong third-quarter results, surpassing analyst expectations for both revenue and earnings. Following these positive results, analysts have modestly increased revenue forecasts for 2027 while maintaining their earnings per share predictions and price target of US$95.00. The company is anticipated …

SR main company
Sharemaestro market context Price below Trend Line 52 weeks +10.7% · Next-week setup positive 60.8% SR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insider Buyers At InspireMD Recover Some Losses, But Still Down US$161k

Insiders at InspireMD bought US$420.8k worth of stock over the last year, but despite a recent 14% stock gain, they are still down US$161k on their purchases. While there was some insider selling, the net insider activity over the year indicates more buying than …

NSPR main company
Sharemaestro market context Price below Trend Line 52 weeks -58.6% · Next-week setup negative 42.7% NSPR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Renaissance Technologies LLC Invests $3.63 Million in Spire Inc. $SR

Renaissance Technologies LLC has invested $3.63 million in Spire Inc. (NYSE:SR), acquiring 40,100 shares and now owning 0.07% of the utility company. Institutional investors hold a significant 87.36% stake in Spire. The company recently reported better-than-expected quarterly revenue of $420.2 million and adjusted EPS …

SR main company
Sharemaestro market context Price below Trend Line 52 weeks +10.7% · Next-week setup positive 60.8% SR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inspired Entertainment (INSE) Stock Slides As Margin Strength Meets Revenue Pressure

Inspired Entertainment (INSE) stock fell 4.8% despite reporting strong adjusted EBITDA margins of approximately 45% in Q2 2026 and reaffirming 2026 guidance. While the company swung to profitability with a net income of US$0.2 million compared to a loss in the prior year, revenue …

INSE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.3% INSE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Class Action Lawsuit Filed Against Inspire Medical Systems, Inc

A securities class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) on behalf of investors who purchased securities between August 6, 2024, and August 4, 2025. The lawsuit alleges that Inspire Medical Systems made false statements and concealed critical issues …

INSP main company
Sharemaestro market context Price above Trend Line 52 weeks -40.5% INSP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ispire Technology Inc (ISPR) Stock News Today

This article provides current stock information for Ispire Technology Inc (ISPR), including its stock price, market capitalization, and a note that more news will be available soon. It highlights that the stock closed at $1.710, up 3.01%, as of August 7th. The page is …

ISPR main company
Sharemaestro market context Price below Trend Line 52 weeks -49.2% ISPR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inspired Entertainment (INSE) awards 593 RSUs to board director

Inspired Entertainment (INSE) has awarded 593 restricted stock units (RSUs) to board director Katja Tautscher due to changes in her board committee roles. A portion of these units (230) vested immediately, with the remainder vesting on October 1, 2026. Settlement of all vested units …

INSE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.3% INSE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

InspireMD Approves 221,666 Restricted Shares for New Hire

InspireMD (Nasdaq: NSPR) has granted 221,666 restricted shares to a new non-executive employee as an inducement for employment, in accordance with Nasdaq Listing Rule 5635(c)(4). These shares, granted under the company's 2024 Inducement Plan with a grant date of August 3, 2026, will vest …

NSPR main company
Sharemaestro market context Price below Trend Line 52 weeks -58.6% · Next-week setup negative 42.7% NSPR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inspire Medical Systems, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:INSP) 2026-08-07

Inspire Medical Systems, Inc. (NYSE:INSP) has released its Q2 2026 earnings call presentation, detailing financial results that exceeded analyst expectations. The company reported an EPS of $0.14, beating estimates by $0.39, and revenue of $200.58M, surpassing expectations by $5.97M despite a 7.60% year-over-year decrease. …

INSP main company
Sharemaestro market context Price above Trend Line 52 weeks -40.5% INSP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inspire Medical Systems, Inc. SEC Filing (Aug 7, 2026)

This article reports on an SEC Form 144 filing by Inspire Medical Systems, Inc. (INSP) on August 7, 2026. The filing indicates a proposed sale of 963 shares of common stock with an aggregate market value of $57,341.84 by a person related to the …

INSP main company
Sharemaestro market context Price above Trend Line 52 weeks -40.5% INSP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

InspireMD, Inc. announced that its Compensation Committee approved inducement grants totaling 221,666 shares of restricted stock to a new non-executive employee. These grants were made outside of the company's 2021 Equity Incentive Plan but under its 2024 Inducement Plan, in accordance with Nasdaq Listing …

NSPR main company
Sharemaestro market context Price below Trend Line 52 weeks -58.6% · Next-week setup negative 42.7% NSPR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inspired Entertainment, Inc. (INSE) stock price, news, quote and history

This Yahoo Finance page provides comprehensive financial information for Inspired Entertainment, Inc. (INSE), a gaming technology company. It includes the current stock price, recent news, chart performance, key statistics, financial data, and analyst ratings. The article details INSE's operations across Gaming, Virtual Sports, Interactive, …

INSE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.3% INSE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

InspireMD Inc (NSPR) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for InspireMD Inc (NSPR), detailing its current earnings forecast score, average price target from analysts, and a comparison with peers. It highlights expected revenue, EPS for past and upcoming quarters, and the overall analyst rating, which leans towards …

NSPR main company
Sharemaestro market context Price below Trend Line 52 weeks -58.6% · Next-week setup negative 42.7% NSPR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lost Money on Inspire Medical Systems, Inc. (INSP)? Urged to Join

Levi & Korsinsky LLP has filed a class action securities lawsuit against Inspire Medical Systems, Inc. (NYSE:INSP) on behalf of investors who suffered losses between August 6, 2024, and August 4, 2025. The lawsuit alleges that Inspire Medical Systems made false statements and concealed …

INSP main company
Sharemaestro market context Price above Trend Line 52 weeks -40.5% INSP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inspired Entertainment, Inc. Stock 12‑Month Price Target Cut to $13.71, Implies 97% Upside

Inspired Entertainment, Inc.'s average 12-month price target has been lowered slightly to $13.71 from $13.86, based on estimates from 7 analysts. This new target suggests a significant potential upside of approximately 97% from its August 5th closing price. The consensus rating for the stock …

INSE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.3% INSE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inspired Entertainment Releases Q2 2026 Financial Results

Inspired Entertainment (INSE) announced Q2 2026 financial results, reporting adjusted earnings of $0.05 per share, significantly beating analyst estimates of a $0.01 loss. However, revenue declined by 24.0% year-over-year to $60.8 million, missing Wall Street forecasts due to struggles in its land-based operations, particularly …

INSE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.3% INSE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inspire Medical Systems, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Inspire Medical Systems (NYSE:INSP) saw an 18% stock price increase after beating Q2 revenue expectations by 3.1% and reporting a statutory profit of US$0.01. Despite this, analysts forecast a revenue reduction for 2026 and expect the company to incur losses, yet they raised the …

INSP main company
Sharemaestro market context Price above Trend Line 52 weeks -40.5% INSP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context